Calculate exact injection volumes, concentrations, and doses per vial for Tesamorelin protocols.
⚠️ Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any peptide or medication protocol.
⚡ Tesamorelin Dose Calculator
Concentration—
Volume Per Injection—
Insulin Syringe Units—
Doses Per Vial—
📱 Track Every Dose with DoseIQ
The #1 peptide tracking app for iPhone. Calculate doses, log injections, set reminders, and track your progress.
Tesamorelin (Egrifta) is a synthetic GHRH analogue FDA-approved for reducing excess abdominal fat in HIV-positive patients with lipodystrophy. The most clinically studied GHRH analogue, with extensive trial data showing 10–15% reduction in visceral adipose tissue. Stimulates pulsatile GH release that targets visceral fat specifically. Also shows cognitive improvements in older adults. Preferred by physicians for anti-aging visceral fat protocols due to FDA approval and robust clinical data.
Tesamorelin Quick Reference
Parameter
Details
Category
Growth Hormone / FDA-Approved
Common Dose
1,000–2,000 mcg
Frequency
Once daily before bed
Half-Life
26 minutes
Injection Sites
Subcutaneous, abdomen
Benefits of Tesamorelin
FDA-approved — most clinically validated GHRH analogue
10–15% reduction in visceral belly fat
Increases GH and IGF-1
Improves cognitive function in older adults
Reduces cardiovascular risk markers
Extensive safety data from clinical trials
Common Dosing Protocols
Anti-Aging: 2 mg daily before bed. 26-week minimum for visceral fat.
Conservative: 1 mg daily for 6–12 months.
Stack: 2 mg tesamorelin + 200 mcg ipamorelin before bed.
Reconstitution Reference Table
Vial Size
BAC Water
Concentration
Low Dose Volume
High Dose Volume
2 mg
2 mL
1,000 mcg/mL
1.0 mL
2.0 mL
2 mg
1 mL
2,000 mcg/mL
0.5 mL
1.0 mL
How to Reconstitute Tesamorelin
1
Add 2 mL BAC water to 2 mg vial ≈ 1,000 mcg/mL
2
2 mg dose = 2.0 mL (use 3 mL syringe) | 1 mg = 1.0 mL
Frequently Asked Questions
Q: Tesamorelin dose?
A: 1–2 mg subcutaneous daily before bed. FDA-approved dose for lipodystrophy: 2 mg/day.
Q: How long to reduce belly fat?
A: Significant visceral fat reduction at 26 weeks. Some reduction from 8–12 weeks.
Q: How to reconstitute?
A: 2 mL BAC water + 2 mg vial ≈ 1,000 mcg/mL. 2 mg dose = 2.0 mL.